These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105. [Late myelopathy after chemonucleolysis. Case report and review of the literature]. Haag P; Münkel K; Meinck HM Nervenarzt; 1999 Oct; 70(10):920-3. PubMed ID: 10554785 [TBL] [Abstract][Full Text] [Related]
106. Update on chymopapain. Shields CB; Arpin EJ Neurol Clin; 1985 May; 3(2):393-403. PubMed ID: 3894923 [TBL] [Abstract][Full Text] [Related]
107. Chymopapain--past and present, future? Ford LT Clin Orthop Relat Res; 1977; (122):367-73. PubMed ID: 319933 [TBL] [Abstract][Full Text] [Related]
108. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide. Skalpe IO Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906 [TBL] [Abstract][Full Text] [Related]
109. Safer proteinase treatment of sciatica. A biochemical preview of chymopapain inhibitors. Grubb A Acta Orthop Scand; 1988 Feb; 59(1):63-5. PubMed ID: 3281407 [No Abstract] [Full Text] [Related]
110. Hemorrhagic complications after the lumbar injection of chymopapain. Buchman A; Wright RB; Wichter MD; Whisler WW; Bosch A Neurosurgery; 1985 Feb; 16(2):222-4. PubMed ID: 3883224 [TBL] [Abstract][Full Text] [Related]